Beacon Pharmaceuticals Limited
- Nature of Business: The Company is engaged in manufacturing and marketing of pharmaceuticals finished Formulation Products and life saving Intravenous (I.V) Fluids, hitech lyophilized anticancer drugs, Active Pharmaceuticals Ingredients (APIs), Bio-tech products & Genetic Engineering products which it sells in the local markets. The Company also provides contract manufacturing and tool manufacturing services.
- Subscription Open: June 20, 2010
- Subscription Close: June 24, 2010
- For Non-Resident Bangladeshi: June 20, 2010 to July 03, 2010
- Reason for IPO: To meet the working capital requirement.
- Offer Price: Per Share Tk. 10.00
- Face Value: Per Share Tk. 10.00
- Market Lot (Shares): 500
- Pre-IPO Paid-up Capital: Tk. 1,900,000,000.00
- Public Offer (Shares): 30,000,000
- Total Issued Shares (after IPO): 220,000,000
- Total Paid-up Capital (after IPO): Tk. 2,200,000,000.00
- EPS (as per Prospectus): Tk. 0.31 (as on 30.06.2009)
- NAV Per Share (after revaluation as per Prospectus): Tk.16.05 (as on 30.06.2009)
- Issue Manager: ICB Capital Management Limited
- Co-Issue Manager: Janata Bank Limited
- Application Document Available at: DSE & CSE Library, DSE Members House, Issue Managers, Underwriter and Designated Banks.
- Website: www.beacon-pharma.com
Posts
